Hepatitis B vaccine: a challenge for Spain
Cerezo Pancorbo, J.M.; García Muñoz, M.T.; Sanchez Badia, J.L.
Anales Espanoles de Pediatria 32(4): 375-376
1990
ISSN/ISBN: 0302-4342 PMID: 2369006 Document Number: 367040
Document emailed within 1 workday
Related Documents
Bruguera, M.; Buti, M.; Diago, M.; García Bengoechea, M.; Jara, P.; Pedreira, J.A.; Ruiz Extremera, A. 1997: Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver Gastroenterologia y Hepatologia 20(9): 467-473Bruguera, M.; Buti, M.; Diago, M.; García Bengoechea, M.; Jara, P.; Pedreira, J.D.; Ruiz Estremera, A. 1998: Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver Medicina Clinica 111(9): 341-346
Yuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
Murphey-Corb, M.; Martin, L.N.; Davison-Fairburn, B.; Montelaro, R.C.; Miller, M.; West, M.; Ohkawa, S.; Baskin, G.B.; Zhang, J.Y.; Putney, S. 1990: A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys Developments in Biological Standardization 72: 273-285
Stevens, C.E.; Taylor, P.E.; Tong, M.J.; Toy, P.T.; Vyas, G.N.; Nair, P.V.; Weissman, J.Y.; Krugman, S. 1987: Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257(19): 2612-2616
Maroto-Navarro, G.; del Mar García-Calvente, M.ía.; Mateo-Rodríguez, I. 2004: The challenge of maternity in Spain: social and health difficulties Gaceta Sanitaria 18(Suppl 2): 13-23
Bravo, L.; Carlos, J.; Gatchalian, S.; Borja-Tabora, C.; Bibera, G.; Willems, P.; Safary, A.; Bock, H.L. 1998: The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth Southeast Asian Journal of Tropical Medicine and Public Health 29(4): 772-778
Akahane, Y. 1981: Development of research on B-type hepatitis virus vaccine---including HBs antigen polypeptide vaccine Nihon Rinsho. Japanese Journal of Clinical Medicine 39(3): 619-630
Faingezicht, I.; Avila-Aguerro, M.L.; Cervantes, Y.; Fourneau, M.; Clemens, S.A.C. 2002: Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Revista Panamericana de Salud Publica 12(4): 247-257
Hu, Z.; Teng, H.; Han, M. 1994: Observation on prevention of hepatitis B virus transmission from mother to baby by hepatitis B vaccine Zhonghua Liu Xing Bing Xue Za Zhi 15(6): 346-348
McIntyre, A.; Nimmo, G.R.; Wood, G.M.; Tinniswood, R.D.; Kerlin, P. 1992: Isolated hepatitis B core antibody--can response to hepatitis B vaccine help elucidate the cause? Australian and New Zealand Journal of Medicine 22(1): 19-22
Inskip, H.M.; Hall, A.J.; Temple, I.K.; Loik, F.; Herbage, E.; Chotard, J.; Whittle, H. 1991: Response to hepatitis B vaccine in relation to the hepatitis B status of family members International Journal of Epidemiology 20(3): 770-773
Curciarello, J.O.; Corallini, O.; Adrover, R.E.; Chiera, A.O.; Giammona, A.M.; Barbero, R.; Apraiz, M.; Belloni, P.O.; Neumann, M.; Jmelnitzky, A.C. 1994: Viral hepatitis infection and response to the hepatitis B vaccine in hemodialyzed patients Acta Gastroenterologica Latinoamericana 25(5): 291-296
Liu, K.Z. 1989: A preliminary study on response to hepatitis B vaccine in subjects with various levels of antibody to hepatitis B surface antigen Zhonghua Yu Fang Yi Xue Za Zhi 23(3): 132-134
Woodruff, B.A.; Stevenson, J.; Yusuf, H.; Kwong, S.L.; Todoroff, K.P.; Hadler, J.L.; Hoyt, M.A.; Mahoney, F.J. 1996: Progress toward integrating hepatitis B vaccine into routine infant immunization schedules in the United States, 1991 through 1994. Connecticut Hepatitis B Project Group Pediatrics 97(6 Part 1): 798-803
Geerligs, H.J.; Weststrate, M.W.; Pertile, T.L.; Rodenberg, J.; Kumar, M.; Chu, S. 1999: Efficacy of a combination vaccine containing MDV CVi 988 strain and HVT against challenge with very virulent MDV Acta Virologica 43(2-3): 198-200
Sunthornchart, S.; Linkins, R.W.; Natephisarnwanish, V.; Levine, W.C.; Maneesinthu, K.; Lolekha, R.; Tappero, J.W.; Trirat, N.; Muktier, S.; Chancharastong, P.; Fox, K.; Donchalermpak, S.; Vitek, C.; Supawitkul, S. 2008: Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005 Addiction 103(10): 1687-1695
Lim, F.Seng.; Han, H-Htay.; Jacquet, J-Marie.; Bock, H.L. 2007: Primary vaccination of infants against hepatitis B can be completed using a combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis-Haemophilus influenzae type B vaccine Annals of the Academy of Medicine Singapore 36(10): 801-806
Liebhaber, H.; Ingalls, T.H.; Le Bouvier, G.L.; Horstmann, D.M. 1972: Vaccination with RA 27-3 rubella vaccine. Persistence of immunity and resistance to challenge after two years American Journal of Diseases of Children 123(2): 133-136
Cheng, H.Kock.; Rajadurai, V.S.; Amin, Z.; Sriram, B.; Yee, M.F.; Han, H.H.; Bock, H.L.; Safary, A. 2004: Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine Southeast Asian Journal of Tropical Medicine and Public Health 35(3): 685-692